Home › Compare › ELXMF vs ADC

ELXMF vs ADC: Dividend Comparison 2026

ELXMF yields 105263.16% · ADC yields 4.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ELXMF wins by $8.064713171987811e+26M in total portfolio value
10 years
ELXMF
ELXMF
● Live price
105263.16%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.064713171987811e+26M
Annual income
$804,966,999,868,734,400,000,000,000,000,000.00
Full ELXMF calculator →
ADC
Agree Realty Corporation
● Live price
4.11%
Share price
$75.38
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$176.9K
Annual income
$79,647.25
Full ADC calculator →

Portfolio growth — ELXMF vs ADC

📍 ELXMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodELXMFADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ELXMF + ADC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ELXMF pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELXMF
Annual income on $10K today (after 15% tax)
$8,947,368.42/yr
After 10yr DRIP, annual income (after tax)
$684,221,949,888,424,200,000,000,000,000,000.00/yr
ADC
Annual income on $10K today (after 15% tax)
$349.45/yr
After 10yr DRIP, annual income (after tax)
$67,700.16/yr
At 15% tax rate, ELXMF beats the other by $684,221,949,888,424,200,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELXMF + ADC for your $10,000?

ELXMF: 50%ADC: 50%
100% ADC50/50100% ELXMF
Portfolio after 10yr
$4.0323565859939053e+26M
Annual income
$402,483,499,934,367,200,000,000,000,000,000.00/yr
Blended yield
99.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

ELXMF
No analyst data
Altman Z
-1.9
Piotroski
4/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+7.5% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELXMF buys
0
ADC buys
0
No recent congressional trades found for ELXMF or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricELXMFADC
Forward yield105263.16% ✓4.11%
Annual dividend / share$2.00$3.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4% ✓
Portfolio after 10y$8.064713171987811e+26M$176.9K ✓
Annual income after 10y$804,966,999,868,734,400,000,000,000,000,000.00 ✓$79,647.25
Total dividends collected$8.063727433132777e+26M$154.7K ✓
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: ELXMF vs ADC ($10,000, DRIP)

YearELXMF PortfolioELXMF Income/yrADC PortfolioADC Income/yrGap
1← crossover$10,537,016$10,526,315.79$10,987$577.21+$10.53M → ELXMF
2$10,377,251,773$10,365,977,166.23$12,293$855.34+$10377.24M → ELXMF
3$9,552,044,282,229$9,540,940,622,831.33$14,088$1,290.70+$9552044.27M → ELXMF
4$8,217,919,074,277,338$8,207,698,386,895,354.00$16,660$1,994.91+$8217919074.26M → ELXMF
5$6,608,173,294,209,699,000$6,599,380,120,800,222,000.00$20,525$3,181.85+$6608173294209.68M → ELXMF
6$4,966,582,566,903,309,000,000$4,959,511,821,478,505,000,000.00$26,654$5,286.90+$4966582566903309.00M → ELXMF
7$3,488,939,161,660,980,000,000,000$3,483,624,918,314,393,500,000,000.00$37,006$9,259.47+$3488939161660979712.00M → ELXMF
8$2,290,823,651,613,942,000,000,000,000$2,287,090,486,710,964,800,000,000,000.00$55,862$17,338.74+$2.2908236516139422e+21M → ELXMF
9$1,405,904,046,772,744,300,000,000,000,000$1,403,452,865,465,517,400,000,000,000,000.00$93,452$35,300.32+$1.4059040467727442e+24M → ELXMF
10$806,471,317,198,781,100,000,000,000,000,000$804,966,999,868,734,400,000,000,000,000,000.00$176,931$79,647.25+$8.064713171987811e+26M → ELXMF

ELXMF vs ADC: Complete Analysis 2026

ELXMF — Stock

Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Asia Pacific, and internationally. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia.

Full ELXMF Calculator →

ADC — REIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this ELXMF vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELXMF vs SCHDELXMF vs JEPIELXMF vs OELXMF vs KOELXMF vs MAINELXMF vs NNNELXMF vs EPRTELXMF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.